Guardant in the News
Patients Don’t Want Colonoscopies – Let’s Give Them Something Better
The life-saving potential of alternative screening methods for colorectal cancer
Blood tests may spare cancer patients chemo
A blood test which can detect traces of cancer cells could spare thousands of patients unnecessary chemotherapy every year.
Liquid Biopsy: Unlocking New Insights to Help Improve Outcomes for Cancer Patients
What if a simple blood draw taken during a routine visit to the doctor for a check-up or a flu shot could allow us to identify specific cancers at an early stage, when they are the most treatable? What if blood tests could help the cancer care team improve patient care at every step of the patient’s journey—from detection to treatment selection to response and recurrence monitoring?
Achieving Diversity in Clinical Trials: Charting a More Equitable Path for Research
One year ago, President Biden reinstated the Cancer Moonshot to reduce the nation’s cancer burden and shed light on inequities in cancer care, calling on both the public and private sectors to help meet this challenge. One area where industry can take initiative is ensuring research and clinical trials capture a diverse patient population.
How Guardant is Redefining Cancer Detection
Guardant Health Scaling Up in San Diego
Close the Gap: Disparities in Cancer Screening Threaten Lives
February marks National Cancer Prevention Month, an initiative to bring awareness to ways Americans can reduce their risk for cancer. While more than 1.7 million Americans will be diagnosed with cancer this year, research suggests that up to 50 percent of cases – and 50 percent of deaths – are preventable. That’s why one key recommendation is to get regular cancer screenings.
Precision Medicine is Transforming Cancer Care
How sophisticated technology and personalized treatment options are enabling more people with advanced cancer to manage and live with their diagnoses for the long-term.